Artemis Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Artemis Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$176M	Buy	3,053,480 +168,182	+6%	+$9.66M	1.57%	11
2026 Q1	$175M	Buy	2,885,298 +1,144,545	+66%	+$66.7M	1.86%	9
2025 Q4	$93.9M	Buy	+1,740,753	New	+$83.7M	1.13%	25
2025 Q2	–	Sell	-242,131	Closed	-$14.8M	–	199
2025 Q1	$14.8M	Buy	+242,131	New	+$14.1M	0.23%	115
2023 Q3	–	Sell	-40,486	Closed	-$2.59M	–	205
2023 Q2	$2.59M	Sell	40,486 -1,491,822	-97%	-$100M	0.03%	181
2023 Q1	$106M	Sell	1,532,308 -351,232	-19%	-$24.8M	1.3%	18
2022 Q4	$136M	Sell	1,883,540 -115,421	-6%	-$8.7M	1.54%	15
2022 Q3	$142M	Buy	1,998,961 +41,541	+2%	+$3.01M	1.62%	12
2022 Q2	$151M	Sell	1,957,420 -28,979	-1%	-$2.21M	1.55%	12
2022 Q1	$145M	Buy	+1,986,399	New	+$133M	1.16%	19
2021 Q4	–	Sell	-195,224	Closed	-$11.5M	–	268
2021 Q3	$11.5M	Buy	195,224 +64,214	+49%	+$4.23M	0.09%	182
2021 Q2	$8.76M	Sell	131,010 -758,402	-85%	-$49.5M	0.08%	211
2021 Q1	$56.1M	Sell	889,412 -111,070	-11%	-$6.91M	0.53%	49
2020 Q4	$62.1M	Sell	1,000,482 -40,055	-4%	-$2.46M	0.65%	48
2020 Q3	$62.7M	Sell	1,040,537 -176,545	-15%	-$10.6M	0.79%	34
2020 Q2	$71.8M	Sell	1,217,082 -596,786	-33%	-$35.7M	0.96%	26
2020 Q1	$101K	Buy	1,813,868 +636,863	+54%	+$38.9M	0.17%	13
2019 Q4	$75.4M	Buy	1,177,005 +856,705	+267%	+$49.1M	0.95%	29
2019 Q3	$16.2M	Buy	320,300 +85,000	+36%	+$3.99M	0.22%	127
2019 Q2	$10.6M	Sell	235,300 -252,000	-52%	-$11.7M	0.13%	189
2019 Q1	$23.3M	Sell	487,300 -994,581	-67%	-$49.5M	0.27%	108
2018 Q4	$77M	Buy	+1,481,881	New	+$79.6M	1%	25
2017 Q4	–	Sell	-166,500	Closed	-$10.6M	–	225
2017 Q3	$10.6M	Buy	166,500 +8,500	+5%	+$496K	0.22%	114
2017 Q2	$8.8M	Buy	+158,000	New	+$8.6M	0.21%	113
2016 Q3	–	Sell	-98,500	Closed	-$7.25M	–	216
2016 Q2	$7.25M	Buy	+98,500	New	+$6.96M	0.2%	134

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Artemis Investment Management's BMY Position: Q2 2026 in Review

Artemis Investment Management increased its Bristol-Myers Squibb (BMY) stake by 5.8% in Q2 2026, buying an estimated $9.66M and bringing the position to 3,053,480 shares worth $176M. The position accounts for 1.57% of the portfolio, ranked #11.

Artemis Investment Management first reported a position in BMY in Q2 2016 and has held it in 25 quarters since. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Artemis Investment Management held 3,053,480 shares of Bristol-Myers Squibb worth $176M as of Q2 2026.
Artemis Investment Management bought 168,182 Bristol-Myers Squibb shares in Q2 2026, an estimated $9.66M.
Bristol-Myers Squibb made up 1.57% of Artemis Investment Management's portfolio in Q2 2026, its #11 holding.
Artemis Investment Management first reported a position in Bristol-Myers Squibb in Q2 2016 and has held it in 25 quarters since.
796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Artemis Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.